News

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
Joie Armstrong knows that a home-cooked meal featuring whole foods is the best way to get her daily nutrients. She takes cues ...
While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...
Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased ...
So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...
Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...
Brown-Forman: GLP-1s, cannabis and Gen Z continue to weigh on demand. Tesla gains as White House aides hint at possible thaw ...
HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...
Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight ...